Become A Clinical Trial Volunteer - Touch Another Life
Uh-oh! This study is no longer available.

We're sorry, but the study or condition you’re looking for is no longer available. You can search all currently enrolling studies or contact us if you have any questions.

Muscle-Invasive Bladder Cancer

Medical Condition

Bladder Cancer


PMG Research of DuPage Medical Group


18 or older




A research study is evaluating an investigational medication used in combination with Nivolumab (OPDIVO®) in those diagnosed with Muscle-Invasive Urothelial Carcinoma of the bladder.

This research study may be an option if you: 
Have a clinical diagnosis of muscle-invasive urothelial carcinoma of the bladder
Are scheduled for radical cystectomy
Are ineligible for or refusing platinum-based neoadjuvant chemotherapy
Have adequate bone marrow, liver, and renal function

Other criteria apply.  Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.

Qualified participants will receive all study-related care and study medication at no cost.



Patient Commitment Duration

Approximately 7 months

Patient Compensation

Financial compensation may be provided for time and travel expenses.  

Number of visits in study

Approximately 7 clinic visits

Apply for this Study Now